Interleukin-10 (IL-10) and interleukin-4 (IL-4), two Th2-derived cytokines, are molecules with anti-inflammatory and immunodeviating properties whose direct expression in allografts may prolong graft survival. Recombinant adenoviruses represent efficient vectors for gene tranfer in quiescent cells in vivo. Adenoviral vectors encoding rat IL-10 (AdIL-10), rat IL-4 (AdIL-4) or ␤-galactosidase (AdlacZ) or without transgene (Addl324) were injected directly into rat hearts at the time of transplantation in order to test their potential to prolong heart allograft survival. Expression of vectorized sequences was confirmed in heart biopsies, and kinetic analysis of ␤-galactosidase showed transient expression. Cardiac allograft survival was significantly prolonged after administration of 10 9 p.f.u. of AdIL-10 (16.6 ± 3.2 days, P Ͻ 0.05), but not AdIL-4 (9.8 ± 1.6 days), Keywords: allotransplantation; gene transfer; cytokines; rat Cytokines are key soluble mediators that regulate the induction, amplification and effector phases of immune responses implicated in rejection and tolerance to grafts. 1 In most experimental allotransplantation models, rejection has generally been associated with high expression of Th1 cytokines (IL-2 and IFN-␥), whereas Th2 cytokines (IL-10 and IL-4) have been detected only weakly or not at all. 1, 2 In tolerance models, most reports have shown that IL-2 and IFN-␥ expression is decreased compared with rejection, whereas the results for Th2 cytokine expression are more controversial; some reports have described a significant increase, while others have shown weak expression of IL-4 and/or IL-10. 1, 2 In certain tolerance protocols, such as the one induced by donor blood transfusion, expression of both Th1 and Th2 cytokines is inhibited in tolerated grafts as compared with levels observed in rejected ones. 3 In this and in other models of tolerance, expression of TGF-␤1 has been clearly implicated in the establishment of tolerance. 3, 4 Furthermore, IFN-␥ and TGF-␤1 seem reciprocally to regulate pro-and compared with Addl324-treated (9.3 ± 3.3 days) or untreated groups (7.8 ± 1.5 days). Immunohistochemical analysis of allografts after gene transfer of IL-10 showed that leukocyte infiltration was quantitatively equivalent to that seen in control groups but with a strong tendency towards lower levels of CD8 + cells. Importantly, adenovirus-derived IL-10 modified the functional status of leukocytes by inducing a significant decrease in IFN-␥ production but significantly increased transforming-growth factor ␤1 (TGF-␤1) expression within the grafts compared with those treated with Addl324. These results show that expression of IL-10 by rat hearts after gene transfer mediated by an adenoviral vector decreases allogeneic immune responses and allows prolongation of allograft survival. Gene Therapy (2000) 7, 505-510.
anti-inflammatory reactions in mucosa and autoimmune models, in certain cases through modulation of Th2 activity. 4 IL-10 is produced by Th2 cells and macrophages and plays an immunosuppressive role by decreasing both the production of pro-inflammatory cytokines and the expression class II major histocompatibility complex (MHC) antigens and antigen-presenting cell function. 5 IL-10 has an indirect down-regulatory action on Th1 cells via inhibition of IL-12 expression by antigen-presenting cells. 6 IL-4 is a growth factor for T cells and is the major inducer of Th2 differentiation. 7 IL-4 acts on B cells as a growth factor and induces immunoglobulin production and isotype switching. 7 On monocytes/macrophages, IL-4 is able to decrease the secretion of pro-inflammatory cytokines but at the same time activates the expression of other molecules, such as surface expression of class II MHC antigens, and the net anti-or pro-inflammatory effects of IL-4 are still controversial. [7] [8] [9] Therefore, IL-10 and IL-4 are pleiotropic cytokines and show certain immunosuppressive and immunodeviating (Th1 to Th2 or to TGF-␤-producing cells) actions, respectively, which make them appealing candidates to be overexpressed in the local graft microenvironment in order to test the hypothesis that these cytokines can prolong allograft survival. Gene transfer is an efficient strategy to counteract the short half-life of cytokines administered systemically by ensuring their continuous production for relatively long periods (few weeks). Gene transfer experiments in the transplantation setting have been performed using a variety of vectors, 10 including recombinant adenoviruses, which have attractive properties for transducing vascularized organs. Recombinant adenoviruses are able to transduce a broad range of cells (including resting cells) with a high efficiency and can be purified at high titers for in vivo experiments.
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In this study, adult rat vascularized cardiac allografts were transduced with recombinant adenoviruses encoding rat IL-4 or IL-10 (AdIL-4 and AdIL-10, respectively) at transplantation in order to analyze the potential immunosuppressive effects of these cytokines. Adenovirus-derived IL-10, but not IL-4, decreased IFN-␥ and increased TGF-␤1 production within the graft and prolonged cardiac allograft survival.
Hearts were transplanted into the abdomen and adenoviruses were immediately injected into the ventricular walls in several different areas while keeping the heart clamped for 30-60 s. The efficiency of cardiac graft transduction with recombinant adenoviruses was determined by injection of AdlacZ into syngeneic transplanted hearts and analysis of ␤-galactosidase expression at later timepoints. Figure 1a illustrates a representative transduced area analyzed by X-galactosidase staining 5 days after gene transfer. ␤-Galactosidase expression was focal, with positive cells essentially located around injection-points but with some diffusion into adjacent cardiac tissue. Higher magnification shows the presence of true cellular transgene expression (Figure 1b ). This expression was transient since no or few positive cells were detected 2 to 3 weeks after gene transfer (n = 2, data not shown). No ␤-galactosidase + cells were detected in control hearts transduced with Addl324 (n = 3). Analysis of lacZ expression in livers 5 days after injection of AdlacZ into transplanted hearts showed the presence of low numbers of ␤-galactosidase + cells (data not shown). Cardiac gene transfer by AdlacZ injection into the myocardium showed no obvious deleterious effects on organ function and allowed efficient expression of ␤-galactosidase. Since nls-␤-galactosidase is retained within the nuclei of transduced cells, cardiac areas occupied by ␤-galactosidase + cells correspond to the area in which adenoviruses were capable of transducing cells. In contrast, when using adenoviruses vectorizing secreted molecules (such as IL-10) that will diffuse from transduced cells, the graft microenvironment that has been modified is likely to be larger than the areas transduced by the injected adenoviruses. Due to the lack of commercially available antibodies to detect rat IL-10 in tissues, this could not be confirmed in hearts transduced with AdIL-10. Nevertheless, using an adenovirus coding for secreted CTLA4Ig (detected with an anti-IgG antibody) we have confirmed widespread tissue distribution in transduced hearts (data not shown). The results obtained with AdlacZ are in agreement with those of other groups where recombinant adenovirus were injected into cardiac muscle. [12] [13] [14] Comparison of intramyocardial injection with intracoronary delivery of adenoviruses in pigs showed a higher transduction efficiency for the former method. 15 Despite the fact that inclusion of compounds which regulate vascular tone and permeability in the adenovirus perfusion solution have been shown greatly to increase transduction efficiency, 16 this method has not a b been followed by heart transplantation, and therefore it is difficult to conclude whether it is applicable in the transplantation setting.
In accordance with previous reports, direct injection of adenoviruses into the graft gave maximal expression between days 3 and 7 after gene transfer, and the transgene could not be detected after 1 month. 14, 15 This transient expression may be due to immune responses against adenoviruses or the transgene itself (such as ␤-galactosidase). 17, 18 As opposed to gene therapy for genetic deficiencies, expression of transgenes in transplantation can be short term. Expression of immunodeviating or immunosuppressive molecules in the initial stages of the immune response allows active tolerance mechanisms to be established that can act independently of the tolerance inductive agent. We have already shown successful prolongation of cardiac allograft survival with this same gene transfer protocol, using an adenovirus coding for TGF-␤1. 3 Furthermore, expression of these immunosuppressive molecules by adenoviruses may also blunt the anti-adenovirus immune response and prolong transgene expression.
Thus, although cardiac gene transfer in the transplantation setting still needs to be improved to obtain a more uniform and longer expression (probably by heart perfusion), in particular in large mammal models, the conditions described here allow reproducible, rapid and reasonably efficient gene transfer with excellent heart graft function.
Despite the fact that expression of biologically active IL-4 and IL-10 derived from AdIL-4 and AdIL-10, respectively, has already been described after gene transfer in the liver, 19 it was relevant to confirm cytokine expression after gene transfer into the heart. To this end, cardiac allografts were injected with 10 9 p.f.u. of AdIL-4 or AdIL-10 and semiquantitative RT-PCR was performed 5 days later using primers specific for transgene sequences to confirm cytokine mRNA expression from adenoviruses. As shown in Figure 2a , adenovirusderived IL-4 mRNA was detected in hearts transduced by AdIL-4, but not in hearts transduced with Addl324. Similarly (Figure 2b ), adenovirus-derived IL-10 mRNA was only detected in hearts transduced by AdIL-10. Adenovirus-derived mRNA for IL-4 and IL-10 were also detected at day 2 after gene transfer (data not shown). Transcripts of the house-keeping gene hypoxanthine phosphoribosyl transferase (HPRT) were amplified at comparable levels in all animals, confirming the presence of intact mRNA in samples from Addl324-transduced hearts.
The effects of IL-10 or IL-4 on cardiac allograft survival were monitored by daily palpation ( Table 1 ). The survival of cardiac allografts was similar between untreated animals (9 ± 0.6 days) and rats injected with 10 9 p.f.u. of Addl324 (9.3 ± 1.1 days). Administration of AdIL-4 did not prolong survival (9 ± 1.6 days) but actually induced death in two of nine recipients. A significant prolongation of cardiac allograft survival was observed when hearts were injected with 10 9 p.f.u. of AdIL-10 (16.6 ± 3.2 days) as compared with untreated animals (P = 0.0003) or with Addl324-injected ones (P = 0.01) (using Kaplan-Meier analysis).
We showed that IL-10 but not IL-4 produced by adenovirus gene transfer was able to prolong rat cardiac allografts but was unable to induce tolerance. IL-10 has been proposed as an immunosuppressive cytokine because of its capacity to down-regulate MHC class II expression, to inhibit antigen-presenting cell functions and to deviate the Th1/Th2 balance to Th2 in vivo. 5 Probably due to these actions, IL-10 has been shown to inhibit allogeneic proliferative and CTL responses in vitro which are initiated either by monocytes or dendritic cells. 20, 21 Furthermore, IL-10 shows anti-inflammatory activity by decreasing the production of pro-inflammatory monokines and increasing the production of molecules with anti-inflammatory activity, such as soluble receptors for TNF␣ and IL-1 receptor antagonist. 5 At present, IL-10 appears to be a cytokine secreted not only by Th2 cells but also by other subpopulations of T cells (Tr1) with suppressive and anti-inflammatory actions in vivo. 22 In addition, IL-10 is also produced by alternatively activated macrophages with suppressive functions. 9 Our results confirm with cellular IL-10, and extend to Gene Therapy 25 found that cationic lipid-mediated gene transfer of cellular IL-10 prolonged the survival of allogeneic hepatocytes in rats. However, contrary to expectations, treatment with a chimeric molecule containing IL-10 and the constant domains of IgG tended to accelerate the destruction of murine islet allografts. 26 Moreover, IL-10 expressed by pancreatic islets of transgenic mice failed to inhibit immune-mediated islet destruction.
27 Surprisingly, Qian et al 28 reported that heart perfusion with recombinant mouse IL-10 had no effect, whereas systemic administration promoted cardiac rejection. These contrasting results may be due to different cellular responses by the same cells from different organs (such as endothelial or dendritic cells), organlocalised cytokine expression versus systemic adminis- tration, nature of IL-10 (viral or cellular), or nature of the graft (vascularized or cellular, newborn or adult).
To determine whether Ad-derived IL-10 acts locally or circulates and acts systemically as well, levels of IL-10 were analyzed by ELISA (Biosource, Camarillo, CA, USA) in rat sera 5 days after AdIL-10 or Addl324 injection into the cardiac graft. IL-10 in the sera of Addl324-treated (n = 3) or AdIL-10-treated (n = 3) rats was below the detection limit of the assay (39 pg/ml). Furthermore, AdIL-10 injected into the muscle of the hind limb at the time of transplantation (10 9 p.f.u.) did not prolong cardiac allograft survival (8 ± 0.6 days, n = 3). These results suggest that the anti-inflammatory and immunodeviating effects of IL-10 expressed after gene transfer into the allografts are restricted to the heart.
The prolongation of allograft survival by Ad-derived IL-10 production and the fact that high IL-10 mRNA accumulation has been described during experimental and clinical allorejection could be seen as a paradox. 1, 29, 30 We analyzed by semiquantitative RT-PCR analysis, as described in the legend of Figure 2 , whether IL-10 was expressed at earlier time-points and at higher levels in hearts transduced with AdIL-10 compared with hearts transduced with Addl324. Total IL-10 mRNA levels (endogenous and adenovirus-derived) at day 2 and 5 after transplantation and gene transfer were four-fold higher (n = 3, P = 0.02) at day 2 and two-fold higher at day 5 (n = 3, P = 0.01) (all statistical analysis of continuous data was analyzed by Student's t test) in hearts injected with AdIL-10 as compared with Addl324-treated hearts. In the rat allograft model used in our study the peak of IL-10 mRNA accumulation is situated at day 5 after transplantation and is concomitant with the production of other pro-inflammatory molecules (TNF␣, IFN␥, IL-2, etc). 30, 31 Therefore, in hearts transduced with AdIL-10, IL-10 is produced at higher levels at earlier time-points (day 2), a time-point at which IL-10 in the absence of other pro-inflammatory molecules could inhibit the development of the allorejection process. Similarly, although TGF␤1 increases during heart allograft rejection in this strain combination and reaches maximal levels between days 5 and 7, earlier expression of TGF␤1 within the graft after adenovirus-mediated gene transfer prolonged allograft survival. 3 In our study, transduction of transplanted hearts with 10 9 p.f.u. of AdIL-4 did not produce a significant change in allograft survival as compared with controls. Several studies have shown that IL-4 production is associated with graft rejection, is not required in tolerance induction, and does not prolong the allograft survival of islets or skin.
1,2,32,33 However, previous reports have shown that administration of IL-4 to rats undergoing donor-specific transfusion and treatment with cyclosporin A has been shown to prolong heart allograft survival, and survival of murine IL-4 transgenic heart allografts has been moderately prolonged compared with non-transgenic hearts. 34, 35 Two of the animals treated with AdIL-4 died with signs of hepatic disfunction. Intraportal administration of AdIL-4 has been shown to result in dose-dependent lethal acute hepatitis, 19 which is partially due to an increase in anti-adenovirus immune responses, 8 but is largely due to a pro-apoptotic effect of IL-4 on hepatocytes. 36 IL-4-mediated hepatic disfunction could be the result of hepatitis due to hepatocyte transduction by a small fraction of AdIL-4 delivered to the graft that reached the liver (as detected with AdlacZ) and/or by circulating IL-4 produced by the graft and inducing hepatocyte apoptosis. In this respect, it should be noted that overexpression of IL-4 was lethal in IL-4 transgenic mice and a phase I study of recombinant human IL-4 resulted in liver dysfunction, indicating direct hepatotoxicity of IL-4. 37, 38 Conventional microscopic examination 5 days after allograft and gene transfer showed a comparable leukocyte infiltration between untreated hearts and those treated with 10 9 p.f.u. of Addl324, AdIL-4 or AdIL-10. Immunohistochemical analysis and morphometric quantification performed by the point-counting technique were used to evaluate leukocyte infiltrates in AdIL-10-transduced hearts and controls. 8, 39 Briefly, positive cells were counted using a square grid in the eyepiece of the microscope on The presence of leukocyte infiltrates in grafts treated with AdIL-10, comparable with the ones observed in untreated controls, is not incompatible with graft acceptance since this same phenomenon is observed in other models of immunosuppression. Prolongation of heart survival and even permanent acceptance after different immunointervention regimens, such as treatment with donor-specific blood transfusions, 30 or administration of CTLA4Ig, 40 has already been observed in the presence of Gene Therapy leukocyte infiltrates of similar intensity and nature to infiltates observed in rejected organs.
Although grafts treated with AdIL-10 or control groups showed quantitatively similar leukocyte infiltrates, the crucial difference is whether they present immunodeviating and immunosuppressive functions, as opposed to the pro-inflammatory and tissue destructive potential of the leukocytes present in grafts that will be rejected. Since IFN-␥ or TGF-␤1 have been shown in this heart allograft model to have strong pro-and anti-rejection effects respectively, 41 we quantified cells producing each cytokine with specific antibodies and morphometric analysis (as explained in the previous section) after gene transfer of IL-10 ( Figure 3) . Cells positive for IFN-␥ (mean ± s.e.) were significantly (P = 0.03) decreased in hearts transduced by AdIL-10 (0.8 ± 0.2, n = 5) as compared with allografts transduced by Addl324 (3.6 ± 1.1, n = 4). In contrast, cells positive for TGF-␤1 were significantly (P = 0.015) increased in hearts transduced by AdIL-10 (11.6 ± 0.9, n = 4) as compared with those treated with Addl324 (5.3 ± 0.7, n = 4). Grafts transduced with AdIL-4 showed numbers of TGF-␤1-positive cells (6 ± 1, n = 3) comparable with those of Addl324-treated grafts.
These results are consistent with the capacity of IL-10 to inhibit IFN-␥ production in vivo and in vitro, either through a direct effect on T cells or indirectly through inhibition of IL-12 production by macrophages. 5 Production of IFN-␥ has been associated with heart allograft rejection in several models, whereas induction of tolerance strongly decreases its expression. 1, 2, 29 Furthermore, exogenous administration of recombinant IFN-␥ in the strain combination used in this study abolishes the establishment of tolerance to allografts induced by donor-specific blood transfusion. 41 In our study, TGF-␤1 expression was enhanced by AdIL-10 as compared with Addl324 treatment. Marth et al 42 showed that TGF-␤ expression is negatively regulated by IL-12 and IFN-␥. Therefore, enhanced TGF-␤1 expression after AdIL-10 administration could be due to inhibition of IFN-␥ production. Increased expression of TGF-␤1 has been shown to play a key role in the development of allograft tolerance by donor-specific blood transfusion and overexpression of TGF-␤1 by adenovirus-mediated gene transfer prolongs allograft survival. 3 Furthermore, Qin et al 43 found that plasmid-mediated gene transfer of TGF-␤1 prolonged murine allograft survival in a model of neonatal cardiac transplantation.
In summary, the adenovirus-mediated gene transfer of IL-10 but not IL-4 prolonged graft survival through transient local immunosuppression rather than the establishment of tolerance. Since transgene expression from first generation recombinant adenovirus is limited on time, new gene transfer vectors allowing prolonged or permanent transgene expression could result in sustained immunosuppression and longer graft survival.
